It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.

Market Analysis and Insights: Global Hydroxyurea API Market
The global Hydroxyurea API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Hydroxyurea API Scope and Market Size
The global Hydroxyurea API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxyurea API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Hydroxyurea Oral
Hydroxyurea Injection

The Hydroxyurea API market is analysed and market size information is provided by regions (countries). Segment by Application, the Hydroxyurea API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
DSM Pharma Chemicals
Nischem International
Bristol-Myers Squibb
Amri
Olon SPA
Qilu Pharmaceutial
Khandelwal Laboratories
Yaksh Pharma